Acute non-Q wave myocardial infarction associated with early ST segment elevation: evidence for spontaneous coronary reperfusion and implications for thrombolytic trials
BL Huey,
M Gheorghiade,
RS Crampton,
GA Beller,
DL Kaiser,
DD Watson,
TW Nygaard,
GB Craddock,
SL Sayre,
and
RS Gibson
The clinical significance of early ST segment elevation in patients with non-Q wave infarction is unknown. Therefore, 150 consecutive patients with creatine kinase isoenzyme-confirmed acute uncomplicated myocardial infarction who had ST segment elevation of 1 mm or more in at least two contiguous leads on the admission electrocardiogram were analyzed. None received thrombolytic therapy or acute coronary angioplasty. Predischarge angiography, radionuclide ventriculography and exercise thallium-201 scintigraphy were performed 10 +/- 3 days after myocardial infarction. Based on serial electrocardiograms (on days 1, 2, 3 and 10), all 150 infarcts were classified as Q wave (n = 115 [77%]) or non-Q wave (n = 35 [23%]). Although patients with Q wave infarction exhibited greater ST elevation, the amount observed in the non-Q wave group was appreciable, as reflected by the number of leads with ST elevation (3.8 +/- 1.8 versus 3.1 +/- 1.2, p = 0.007) and the sum of the ST elevation (9.6 +/- 7.4 versus 6.2 +/- 6.2 mm, p = 0.016). When compared with the Q wave group, patients with non-Q wave infarction had a shorter time to peak creatine kinase (23.0 +/- 9.1 versus 15.8 +/- 7.9 hours, p = 0.0001), a higher infarct vessel patency rate (24 versus 57%, p = 0.001), lower peak creatine kinase values based on 4 hour sampling (1,372 +/- 964 versus 664 +/- 924 IU/liter, p = 0.0002) and a higher left ventricular ejection fraction (46 +/- 12% versus 54 +/- 9%, p = 0.0003).(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
|
|
 
D Rimar, E Crystal, A Battler, S Gottlieb, D Freimark, H Hod, V Boyko, L Mandelzweig, S Behar, and J Leor
Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction
Heart,
October 1, 2002;
88(4):
352 - 356.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Scanlon, D. P. Faxon, A.-M. Audet, B. Carabello, G. J. Dehmer, K. A. Eagle, R. D. Legako, D. F. Leon, J. A. Murray, S. E. Nissen, et al.
ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions
J. Am. Coll. Cardiol.,
May 1, 1999;
33(6):
1756 - 1824.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. G. Goodman, A. Langer, A. M. Ross, N. M. Wildermann, A. Barbagelata, E. B. Sgarbossa, G. S. Wagner, C. B. Granger, R. M. Califf, E. J. Topol, et al.
Non Q-Wave Versus Q-Wave Myocardial Infarction After Thrombolytic Therapy : Angiographic and Prognostic Insights From the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries I Angiographic Substudy
Circulation,
February 10, 1998;
97(5):
444 - 450.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Berger, J. M. Murabito, J. C. Evans, K. M. Anderson, and D. Levy
Prognosis After First Myocardial Infarction: Comparison of Q-Wave and Non-Q-Wave Myocardial Infarction in the Framingham Heart Study
JAMA,
September 23, 1992;
268(12):
1545 - 1551.
[Abstract]
[PDF]
|
|
|
|
